Zhejiang Yingkang Biopharmaceutical

Zhejiang Yingkang Biopharmaceutical is a China-based biotechnology company focused on the research, development, and commercialization of innovative vaccines and therapeutic biologics. The company leverages advanced recombinant protein expression platforms to address significant unmet needs in infectious diseases and oncology. Its primary pipeline includes high-valence human papillomavirus (HPV) vaccines and candidates for respiratory syncytial virus (RSV) and shingles. Zhejiang Yingkang aims to provide high-quality, affordable biopharmaceutical products to global markets through its integrated R&D and manufacturing capabilities.